This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Lindsay (LNN) Gains From Solid Demand Despite Higher Costs
by Zacks Equity Research
Lindsay (LNN) benefits from strong demand, driven by high agricultural commodity prices and strong business growth, offset by higher input costs.
Here's Why You Should Give Illinois Tool (ITW) a Shot Now
by Zacks Equity Research
Strength in the capital equipment and industrial businesses and growth in industrial applications and automotive aftermarket construction augur well for Illinois Tool Works (ITW).
The Zacks Analyst Blog Highlights Microsoft, Alibaba Group, Medtronic, Illinois Tool Works and Fiserv
by Zacks Equity Research
Microsoft, Alibaba Group, Medtronic, Illinois Tool Works and Fiserv are part of the Zacks top Analyst Blog.
Zacks Industry Outlook Highlights Illinois Tool Works, Ingersoll Rand, Helios Technologies and Manitex International
by Zacks Equity Research
Illinois Tool Works, Ingersoll Rand, Helios Technologies and Manitex International are part of the Zacks Industry Outlook article.
Top Stock Reports for Microsoft, Alibaba & Medtronic
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Alibaba Group Holding Limited (BABA) and Medtronic plc (MDT).
4 Industrial Manufacturing Stocks to Gain From Improved Supply Chains
by Eshani Haque
Easing supply chain issues bode well for the Zacks Manufacturing - General Industrial industry's near term. ITW, IR, HLIO and MNTX are expected to make the most of this buoyancy in the industry.
Xylem (XYL) Down 4.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Stocks to Buy as Interest Rates Rise
by Ethan Feller
The Fed is worried that inflation will continue to run too hot, and they must continue to raise rates to fight this trend
Illinois Tool Works (ITW) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Illinois Tool Works (ITW) have what it takes? Let's find out.
Beat the Market the Zacks Way: Oracle, Medtronic, Uber in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Has Illinois Tool Works (ITW) Outpaced Other Industrial Products Stocks This Year?
by Zacks Equity Research
Here is how Illinois Tool Works (ITW) and O-I Glass (OI) have performed compared to their sector so far this year.
Illinois Tool Works (ITW) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Illinois Tool Works (ITW) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Illinois Tool (ITW) Up 18.4% in 6 Months: What's Driving It?
by Zacks Equity Research
Illinois Tool (ITW) benefits from strong demand across its businesses and accretive buyouts. Its shareholder-friendly measures are also encouraging.
Beat the Market the Zacks Way: Kazia Therapeutics, Uber, Medtronic in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Illinois Tool Works (ITW) have what it takes? Let's find out.
Here's How Much a $1000 Investment in Illinois Tool Works Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Are Industrial Products Stocks Lagging Illinois Tool Works (ITW) This Year?
by Zacks Equity Research
Here is how Illinois Tool Works (ITW) and MRC Global (MRC) have performed compared to their sector so far this year.
Take the Zacks Approach to Beat the Market: Ulta Beauty, Clorox, Similarweb in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Why Illinois Tool Works (ITW) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Illinois Tool Works (ITW) have what it takes? Let's find out.
Illinois Tool Works (ITW) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Illinois Tool Works (ITW) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Illinois Tool Works (ITW) Q4 Earnings Miss, Revenues Beat
by Zacks Equity Research
Illinois Tool Works' (ITW) Q4 results benefit from higher sales across most segments. However, adverse foreign currency movements hurt sales by 5%.
Illinois Tool Works (ITW) Lags Q4 Earnings Estimates
by Zacks Equity Research
Illinois Tool Works (ITW) delivered earnings and revenue surprises of -10% and 2.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Illinois Tool Works (ITW) This Earnings Season?
by Zacks Equity Research
Illinois Tool Works (ITW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Ball Corp (BALL) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Ball Corporation's (BALL) Q4 results are likely to reflect the recent deceleration of customer demand, particularly in the United States, as well as elevated raw material and manufacturing costs.
Xylem (XYL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Xylem (XYL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.